Holen Sie sich die Stockscreener-App
0.695
0.72%
0.005
Schlusskurs vom Vortag:
$0.69
Offen:
$0.6802
24-Stunden-Volumen:
10,542
Relative Volume:
0.08
Marktkapitalisierung:
$2.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.14M
KGV:
-0.0958
EPS:
-7.2511
Netto-Cashflow:
$-4.79M
1W Leistung:
-3.47%
1M Leistung:
-21.02%
6M Leistung:
-61.60%
1J Leistung:
-56.56%
1-Tages-Spanne:
$0.6802
$0.695
1-Wochen-Bereich:
$0.6603
$0.7091
52-Wochen-Spanne:
$0.64
$4.25
Bone Biologics Corp Stock (BBLG) Company Profile
Firmenname
Bone Biologics Corp
Sektor
Branche
Telefon
(781) 552-4452
Adresse
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Vergleichen Sie BBLG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.695 | 2.36M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
131.53 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
94.88 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
347.59 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.33 | 106.51B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.45 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Bone Biologics Corp Aktie (BBLG) Neueste Nachrichten
Orthobiologics Market Set to Witness Significant Growth - openPR.com
When (BBLGW) Moves Investors should Listen - news.stocktradersdaily.com
BBLG stock touches 52-week low at $0.7 amid market challenges - Investing.com Canada
BBLG stock touches 52-week low at $0.7 amid market challenges By Investing.com - Investing.com South Africa
Bone Biologics (OTC:BBLG) Trading 1.9% Higher – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bone Biologics sets date for 2025 annual meeting - Investing.com
Top Trend In Orthobiologics Devices And Equipment Market 2025: Biodegradable Implants Transforming Orthobio... - WhaTech
Orthobiologics Market Future Business Opportunities - openPR.com
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors - The Malaysian Reserve
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Bone Biologics (OTC:BBLG) Trading 1.2% Higher – Here’s Why - Defense World
MTF Biologics Collaborates with Kolosis BIO to Boost DBX Brand - World Business Outlook
MTF Biologics Expands Partnership with Kolosis BIO to Strengthen DBX Brand - StreetInsider.com
TETROUS®, INC. SUCCESSFULLY CLOSES FINANCING ROUND, SECURING ADDITIONAL CAPITAL FOR FUTURE GROWTH - PR Newswire
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Down 15.9% in February - Defense World
BBLG stock touches 52-week low at $0.8 amid market challenges - Investing.com
Orthobiologics Market Generated Opportunities, Future Scope - openPR
BBLG: Funding Looks Good as Trials Continue - Research Tree
Bone Biologics Corp SEC 10-K Report - TradingView
Orthobiologics Market : Comprehensive Overview, Trends, and Future Outlook 2025-2035 - PharmiWeb.com
Key Bone Void Fillers Market Trend 2025-2034: Advancements In Bone Healing Through Carbohydrate Polymer Tec... - WhaTech
Bone Biologics (BBLG) Expected to Release Quarterly Earnings on Wednesday - Defense World
Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga
Bone Biologics (NASDAQ:BBLG) Stock Quotes, Forecast and News Summary - Benzinga
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Trevi Therapeutics Inc (TRVI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
OMI’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
CNQ’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
Edison International (EIX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
BBLG’s Stock Journey: What Investors Need to Know About Bone Biologics Corp’s Performance - The InvestChronicle
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Up 9.8% in January - Defense World
(BBLGW) Technical Pivots with Risk Controls - Stock Traders Daily
Spine Biologics Market Research to 2030: Expansion Fueled - GlobeNewswire
Bone Biologics (OTC:BBLG) Trading Down 6.9% – Here’s Why - Defense World
The Bone Growth Products Market to Hit Revenue of $1.35 Billion by 2029, Mergers & Acquisition Trends Set to Drive Market ExpansionArizton - Industry Today
(BBLGW) Trading Report - Stock Traders Daily
An innovative advance in bone grafting: initial clinical results using a novel integrative bone graft in spinal fusion - Frontiers
Bone Biologics (OTC:BBLG) Trading Up 13% – Should You Buy? - Defense World
(BBLGW) Trading Advice - Stock Traders Daily
What Analysts Think About Bone Biologics Corp (NASDAQ: BBLG)’s Potential Raise - Stocks Register
Head to Head Contrast: Bone Biologics (NASDAQ:BBLG) vs. Establishment Labs (NASDAQ:ESTA) - Defense World
Orthobiologics Devices And Equipment Market Size, Growth, Trends And Forecast To 2033 - openPR
Orthobiologics Market Overall Study Report 2024-2031 | Zimmer - openPR
Bone Biologics updates ATM offering agreement terms By Investing.com - Investing.com Australia
Bone Biologics updates ATM offering agreement terms - Investing.com
Finanzdaten der Bone Biologics Corp-Aktie (BBLG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.85%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):